What is the recommended dose for a lignocaine (lidocaine) infusion in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosing for Lignocaine (Lidocaine) Infusion in Adults

For adult patients requiring intravenous lidocaine infusion, the recommended dosing is a loading dose of 1.5 mg/kg given over 10 minutes, followed by a maintenance infusion of 1.5 mg/kg/h, with a maximum duration of 24 hours. 1

Detailed Dosing Protocol

Initial Loading Dose

  • Loading dose: 1.5 mg/kg administered over 10 minutes
  • Must be given with an anesthetist present
  • Should be completed before skin incision if used perioperatively
  • Monitoring requirements during loading dose:
    • Continuous ECG
    • Pulse oximetry
    • Blood pressure every 5 minutes during initial infusion and for first 15 minutes thereafter

Maintenance Infusion

  • Standard infusion rate: 1.5 mg/kg/h
  • Maximum duration: 24 hours
  • If extended beyond 24 hours (rare cases), reduce rate to 50% and obtain consultant approval

Administration Requirements

Equipment

  • Dedicated infusion device that is:
    • Labeled
    • Lockable and tamper-proof
    • Adjustable with fixed rate and upper limit settings
    • Equipped with anti-siphon and anti-reflux mechanisms
  • Separate dedicated cannula
  • Minimum flow of sodium chloride 0.9% at 10 ml/h from a dedicated fluid bag
  • One-way valve to prevent retrograde flow
  • ISO-standard grey "lidocaine" label on the infusion line
  • Separate lidocaine monitoring chart

Monitoring

  • Outside operating theater/recovery room:
    • Ideally in a monitored bedspace (high dependency unit)
    • Observations every 15 minutes for first hour, then hourly
    • Continuous ECG monitoring
    • Trained staff who can recognize signs of toxicity

Safety Considerations

Maximum Safe Doses

  • With epinephrine: Maximum 7 mg/kg (not to exceed 500 mg total)
  • Without epinephrine: Maximum 4.5 mg/kg (not to exceed 300 mg total) 2

Toxicity Warning Signs

  • Early neurological symptoms (most important to monitor):
    • Perioral tingling
    • Tinnitus
    • Light-headedness
    • Restlessness
  • Cardiovascular signs are late manifestations

Contraindications and Precautions

  • Use ideal body weight rather than actual body weight for dose calculations 3
  • Patients weighing less than 40 kg are contraindicated for IV lidocaine infusions 3
  • Reduce doses in elderly patients and those with liver or cardiac disease 2
  • Avoid concurrent use of 5% lidocaine medicated plasters 1

Post-Infusion Considerations

  • No nerve or fascial plane blocks should be performed until 4 hours after completion of infusion
  • Boluses of local anesthetic must not be given into wound catheters or epidural catheters until 4 hours after completion
  • Infusions (without boluses) through wound or epidural catheters may be started 30 minutes after the infusion has been stopped 1

Special Clinical Situations

Ventricular Tachycardia Management

For ventricular tachycardia, the British Journal of Sports Medicine recommends:

  • Initial bolus: 50 mg IV over 2 minutes
  • Repeat every 5 minutes to a total dose of 200 mg
  • Start infusion at 2 mg/min 1

Bronchoscopy Procedures

For bronchoscopy, the British Thoracic Society recommends:

  • Total dose should be limited to 8.2 mg/kg (approximately 29 ml of 2% solution for a 70 kg patient)
  • Use minimum amount necessary when instilled through the bronchoscope
  • Extra caution in elderly or those with liver or cardiac impairment 1

By following these guidelines, clinicians can safely administer intravenous lidocaine while minimizing the risk of toxicity and optimizing therapeutic benefits for patients requiring this intervention.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pain Management Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.